Guillain-Barré Syndrome after Thrombolysis with Streptokinase

Guillain-Barre syndrome (GBS) is an eponym for a heterogeneous group of immune-mediated peripheral neuropathies. We describe a case of GBS in a patient who recieved intravenous streptokinase therapy for acute anterior myocardial infarction. Clinical symptoms are thought to result from streptokinase-...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuyan, Ertugrul, Cakar, Mehmet Akif, Dinckal, Mustafa H.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014663/
https://www.ncbi.nlm.nih.gov/pubmed/21234097
http://dx.doi.org/10.4061/2010/315856
_version_ 1782195365258199040
author Okuyan, Ertugrul
Cakar, Mehmet Akif
Dinckal, Mustafa H.
author_facet Okuyan, Ertugrul
Cakar, Mehmet Akif
Dinckal, Mustafa H.
author_sort Okuyan, Ertugrul
collection PubMed
description Guillain-Barre syndrome (GBS) is an eponym for a heterogeneous group of immune-mediated peripheral neuropathies. We describe a case of GBS in a patient who recieved intravenous streptokinase therapy for acute anterior myocardial infarction. Clinical symptoms are thought to result from streptokinase-antibody complex mediated damage to the local blood-nerve barrier. Patient was treated with 5-days course of intravenous gammaglobulin and his outcome was good.
format Text
id pubmed-3014663
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-30146632011-01-13 Guillain-Barré Syndrome after Thrombolysis with Streptokinase Okuyan, Ertugrul Cakar, Mehmet Akif Dinckal, Mustafa H. Cardiol Res Pract Case Report Guillain-Barre syndrome (GBS) is an eponym for a heterogeneous group of immune-mediated peripheral neuropathies. We describe a case of GBS in a patient who recieved intravenous streptokinase therapy for acute anterior myocardial infarction. Clinical symptoms are thought to result from streptokinase-antibody complex mediated damage to the local blood-nerve barrier. Patient was treated with 5-days course of intravenous gammaglobulin and his outcome was good. SAGE-Hindawi Access to Research 2010-12-26 /pmc/articles/PMC3014663/ /pubmed/21234097 http://dx.doi.org/10.4061/2010/315856 Text en Copyright © 2010 Ertugrul Okuyan et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Okuyan, Ertugrul
Cakar, Mehmet Akif
Dinckal, Mustafa H.
Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title_full Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title_fullStr Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title_full_unstemmed Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title_short Guillain-Barré Syndrome after Thrombolysis with Streptokinase
title_sort guillain-barré syndrome after thrombolysis with streptokinase
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014663/
https://www.ncbi.nlm.nih.gov/pubmed/21234097
http://dx.doi.org/10.4061/2010/315856
work_keys_str_mv AT okuyanertugrul guillainbarresyndromeafterthrombolysiswithstreptokinase
AT cakarmehmetakif guillainbarresyndromeafterthrombolysiswithstreptokinase
AT dinckalmustafah guillainbarresyndromeafterthrombolysiswithstreptokinase

Ejemplares similares